Bispecific T cell engager therapy for refractory rheumatoid arthritisLaura Bucci, Ricardo Grieshaber‐Bouyer, Milena Pachowsky et al.|Nature Medicine|2024Cited by 147
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune DiseaseMelanie Hagen, Ricardo Grieshaber‐Bouyer, Laura Bucci et al.|New England Journal of Medicine|2024Cited by 111
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Christina Bergmann, Fabian Müller et al.|The Lancet Rheumatology|2024Cited by 96
Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphomaFabian Müller, Simon Völkl, Nora Rebecca Schwingen et al.|Blood|2025Cited by 27
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune DiseaseLaura Bucci, Ricardo Grieshaber‐Bouyer, Sebastian Boeltz et al.|New England Journal of Medicine|2025Cited by 15